Pathogenic Mechanisms in Thalassemia II: Iron Overload

By sjmartinez • March 13, 2023

Ganz T, Nemeth E. Pathogenic Mechanisms in Thalassemia II: Iron Overload. Hematol Oncol Clin North Am. 2023 Apr;37(2):353-363. doi: 10.1016/j.hoc.2022.12.006. PMID: 36907608.

Tags: Erythroferrone, Hepcidin, Ineffective erythropoiesis, Nontransferrin-bound iron, Publications, Pulmonary, Critical Care & Sleep Medicine

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Lao CD, Moon J, Ma VT, Fruehauf JP, Flaherty LE, Bury MJ, Martin WG, Gross H, Akerley W, Hopkins JO, Patel SP, Sondak VK, Ribas[...]

The interventional esophagologist: tunneling a new way forward

Skef W, Kolb JM, Samo S, Legget CL, Otaki F, Konda VJA. The interventional esophagologist: tunneling a new way forward. Dis Esophagus. 2024 Sep 28:doae078.[...]

Assessing Healthcare Transition Readiness in Adolescents with Asthma through a Portal-Based Initiative

Tsevat RK, Ma J, Duan S, Chen L, Tarn DM, Ross MK. Assessing Healthcare Transition Readiness in Adolescents with Asthma through a Portal-Based Initiative. J[...]